Home / COVID-19 Coverage / URMC testing antiviral drug to treat COVID-19 patients

URMC testing antiviral drug to treat COVID-19 patients

1022557487_research-img-72dpi_5631_976x710The University of Rochester Medical Center announced today its participation in a clinical trial sponsored by the National Institute of Health to evaluate the safety and effectiveness of antiviral drug remdesivir for adult patients hospitalized with COVID-19.

Ann Falsey M.D. and Angela Branche M.D. lead the study alongside the URMC Vaccine Trials and Evaluation Unit (VTEU).

Remdesivir was developed by Gilead Sciences. It’s a broad-spectrum antiviral drug that has been tested in humans with the Ebola virus. Remdesivir has also been effective in treating illnesses caused by other coronaviruses like Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) in animals.

The trial is double-blind and placebo-controlled. Acute COVID-19 patients at Strong Memorial Hospital will be used in the study. In the future, the study may grow to include other antiviral treatments that the VTEU wants to test.

nsheldon@bridgetowermedia.com / (585) 363-7031

Leave a Reply

Your email address will not be published.


Check Also

Five Star Bank's headquarters in downtown Rochester (photo provided by Five Star Bank).

Five Star Bank donates $20,000 to PathStone Enterprise Center (access required)

Five Star Bank has donated $20,000 to PathStone Enterprise Center, which strives to promote economic growth and enhance community wealth-building of ...


Incentives approved for Genesee County’s sixth solar project (access required)

The Genesee County Economic Development Center has approved incentives for a $6 million solar project in the town of Batavia. ...